Pepdox
Studies
Peptides
Calculator
Oral Semaglutide: Balancing Promising Therapeutics with Adverse Effects and Access Barriers. | Pepdox
Home
/
Search
/
PMID 32857647
Oral Semaglutide: Balancing Promising Therapeutics with Adverse Effects and Access Barriers.
Journal of managed care & specialty pharmacy
2020
PMID: 32857647
View on PubMed
DOI: 10.18553/jmcp.2020.26.9.1077
Semaglutide
Abstract
No funding was received for this commentary. The author has nothing to disclose.
Authors
Gunning, Karen